Literature DB >> 31528737

Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences.

Yudianita Kesuma1,2, Agus Firmansyah3, Saptawati Bardosono4, Ika Puspa Sari5, Agnes Kurniawan5.   

Abstract

OBJECTIVE: IBS is a functional gastrointestinal disorder and commonly presents in children and adolescences, presented as diarrhoea, constipation or mixed type. Blastocystis is a common intestinal protozoa found worldwide, which pathogenicity is still controversial. This study aimed to identify the risk factors of IBS, the association between IBS types with Blastocystis subtypes and analyse Blastocystis pathogenicity.
DESIGN: A comparative cross-sectional study was conducted among senior high school students. Rome III Criteria for IBS diagnosis, questionnaires on the risk factors of IBS and types of IBS were recorded. Students were further selected and classified into IBS and non-IBS groups to analyse the association between IBS, IBS types with Blastocystis infection and its subtypes. Direct microscopic stool examination to identify single Blastocystis infection was performed, followed by culture in Jones' medium, PCR, sequencing of 18S rRNA and phylogenetic analysis to determine Blastocystis subtype. Data was analysed using SPSS v22.0 and P value <0.05 was considered statistically significant (95% confidence intervals).
RESULTS: IBS was found in 30.2% of 454 students, consisted of 33.3% IBS Diarrhoea, 27.7% IBS Mixed, 27.7% IBS Unclassified and 11.1% IBS Constipation. Major risk factors to IBS consisted of family history of recurrent abdominal pain, abuse, bullying and female gender in respective order (OR 3.6-2.1). Blastocystis ST-1 was significantly associated to IBS-D with 2.9 times risk factor.
CONCLUSIONS: Blastocystis infection is a risk factor to develop IBS-D type in adolescence; Blastocystis ST-1 can be regarded as a pathogenic subtype.

Entities:  

Keywords:  Diarrhoea; Intestinal protozoa; Irritable bowel syndrome; Risk factors

Year:  2019        PMID: 31528737      PMCID: PMC6742775          DOI: 10.1016/j.parepi.2019.e00112

Source DB:  PubMed          Journal:  Parasite Epidemiol Control        ISSN: 2405-6731


Introduction

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder (FGID) characterized by abdominal pain or discomfort with defecation disorders (Hyams et al., 1996). It is commonly present in children and adolescences without abnormality on physical examination. Prevalence of IBS is higher than other gastrointestinal disorders, in developing and developed countries which is about 10–15% and 21% in school children and adolescences respectively in the UK. In Asia, the IBS prevalence were 2.9–15.6% in school children and 5.8–25.7% among adolescences (Lee, 2010; Dong et al., 2005; Chang et al., 2010). A lower prevalence was observed among adolescences in Jakarta (Fillekes et al., 2014). IBS can be categorized into four subtypes according to Rome III criteria, Bristol scale: Diarrhoea type, Constipation type, Mixed type and Unclassified (Rajindrajith and Devanarayana, 2012). The exact aetiology of IBS remains to be determined, whether it is caused by hereditary or environmental factors such as Blastocystis infection, as was reported in Pakistan (Rajindrajith and Devanarayana, 2012). It is possibly due to complex interaction between infection, inflammation, visceral hypersensitivity, allergy and gut motility disorders (Dong et al., 2005; Apley and Naish, 1958). Blastocystis is a common intestinal parasite with extensive genetic variability; its pathogenic potential in human intestine is still controversial because it is found in symptomatic and asymptomatic individuals (Self et al., 2014; Yakoob et al., 2010a; Yakoob et al., 2004; Ramirez-Miranda et al., 2010). There has been quite a few studies looking for the association between IBS and Blastocystis but has not come into one consensus on the pathogenicity of Blastocystis in IBS. Recent surveys on parasites infection among children and adolescence in Indonesia showed 30% and 40% Blastocystis spp. prevalence respectively (Sari et al., 2018; Sungkar et al., 2015). The clinical consequences of Blastocystis infection are mainly diarrhoea or abdominal pain with nonspecific gastrointestinal symptoms (Self et al., 2014; Yakoob et al., 2010a, Yakoob et al., 2004; Ramirez-Miranda et al., 2010). This study aimed to conduct extensive analysis on IBS in the community to find the risk factors of IBS in adolescence and IBS relation to Blastocystis infection.

Methods

A prospective cross-sectional study was carried out in two stages. The first stage aimed to identify the risk factors of IBS among adolescences. The second stage was to analyse the role of Blastocystis and its subtypes in IBS and non-IBS groups. According to sample size formula calculation, a minimum number of 70 subjects in each group were required for statistical analyses.

Study population

To identify the risk factors associated to IBS among adolescences, a community-based survey was conducted with comparative cross sectional two groups among six senior high school students in Palembang-South Sumatra which is one-hour flight from Jakarta, followed by a minimum 2 h local transport. Student's general characteristics and physical examination were recorded. Nutritional status was determined based on anthropometric examination and plotted onto the CDC growth chart. The Rome III criteria for IBS diagnosis was applied i.e. abdominal discomfort or pain at least once per week for >2 months and it was associated with at least two of the three following features for at least 25% of the time: (1) Abdominal pain improved with defecation, (2) Onset associated with change in defecation frequency, (3) Onset associated with change in stools consistency. The inclusion criteria were good health; those with chronic diseases such as asthma, diabetes mellitus, all variant of heart, renal and blood diseases, congenital anomaly were excluded. Those who had received antibiotics and antiparasitic treatment (metronidazole, tinidazole, albendazole) in the last two weeks were also excluded. A team was formed consisting of five physicians, trained in detail for IBS identification and understanding the questionnaire. Questionnaire was developed, based on the recommendation of the Rome III Criteria and distributed among the students on school visits; understanding of the questions was assisted by the investigators (Hyams et al., 2016). Inform consent was obtained from school administrators and parents before commencing the study. There were 454 adolescences eligible to participate in the first stage of this study. They were interviewed and underwent physical examination to identify the presence of IBS, and then were classified into IBS and non-IBS groups. To identify the association between IBS and Blastocystis infection; subjects from each group were further selected by simple random sampling, with minimum 70 subjects for each group according to the sample size formula calculation (Fig. 1).
Fig. 1

Study workflow diagram.

^minimum sample requirement based on the sample size calculation formula.

Study workflow diagram. ^minimum sample requirement based on the sample size calculation formula.

Diagnostic criteria for IBS and IBS subtypes (Rajindrajith and Devanarayana, 2012)

Subjects with IBS were classified into four subtypes according to Rome III-Bristol scale: IBS with constipation (IBS-C) when hard or lumpy stools for at least ≥25% of the time; IBS with diarrhoea (IBS-D) when loose, mushy or watery stools for at least ≥25% of defecations; IBS with either hard or lumpy stools and loose, mushy or watery stools for ≥25% of defecations were identified as mixed IBS (IBS-M). Those fulfilled the criteria without diarrhoea and constipation were grouped as unclassified IBS (IBS-U).

Identification of Blastocystis spp.

Microscopic examination with 1% lugol solution was carried out on sub-sample 207 stools, originated from all IBS individuals (n = 137) and 70 non-IBS (Fig. 1). Approximately 2 mg of feces was smeared on a glass slide with one drop lugol solution and covered with a cover slip, examined under medium power (40×) objective lens. Stools positive for Blastocystis spp. were cultured in Jones' medium supplemented with 10% horse serum (Leelayoova et al., 2002) to amplify the number of Blastocystis. Cultures were incubated at room temperature then transported to Parasitology laboratory in Jakarta.

DNA isolation and amplification (Scicluna et al., 2006)

DNA was extracted from the cultures using QIAamp DNA Mini Kit following the procedure from the manufacturer (Qiagen, GmbH, cat no. 51306) and kept in −20 °C. PCR amplification of 18S rRNA was performed in 25 μl reaction with TopTaq Polymerase Master Mix Kit (Qiagen, cat no. 200403), 200 mM each dNTP, 10% Bovine Serum Albumin and 2 μl DNA template. The primers were as follows: Forward: RD5 5′-ATC-TGG-TTG-ATC-CTG-CCA-GT-3′ Reverse: BhRDr 5′-GAG-CTT-TTT-AAC-TGC-AAC-AAC-G-3′ The PCR reactions were carried out on MJ Research PTC 200 thermocycler and adjusted for optimum reaction, consisted of: 1 cycle at 95 °C for 6 min then 30 cycles at 93 °C for 2 min, 65 °C for 2 min, 72 °C for 2 min. The last cycle was 10 min at 72 °C. The 600 bp PCR product was electrophoresed on 2% agarose gel and visualized with UV transilluminator.

DNA sequencing and subtype analysis

All the amplicons underwent bi-directional sequencing, the chromatograms were validated. Blasted sequences were aligned to Blastocystis database from the GenBank, using Mega 6 software (en.bio-soft.net/tree/MEGA.htm). Phylogenetic tree was set up employing the Maximum Likelihood method and Kimura 2-parameter model (Kimura, 1980). The tree with the highest log likelihood (−2575.97) is shown. Evolutionary analyses were conducted in MEGA X software (Kumar et al., 2018).

Statistical analysis

Results were expressed as the mean and standard deviation (SD) for continuous variables and percentage for categorical data as univariate analysis. An independent sample t-test, Pearson chi-square test and/or Fisher's exact test were also used whenever appropriate and P value <0.05 was considered statistically significant (95% confidence intervals). All P values were two sided. Data was analysed using SPSS v22.0 statistical package. The study was approved by the Ethics Committee, Faculty of Medicine, Universitas Indonesia (774/UN2.F1/ETIK/2017; 21st August 2017).

Results

Risk factors to IBS

Table 1 shows the profile of the study population. As many as 454 high school students were enrolled in this study, consisted of 37.2% males and 62.8% females; with average age of 15.8 ± 0.97 year. IBS was found in 137 students (30.2%). The risk factors related to IBS that showed significant associations can be classified into high risk (OR > 3.0) consisted of family history of recurrent abdominal pain, psychosocial problems (abuse); moderate risk (2 < OR ≤ 3), consisted of bullying, Blastocystis infection, female gender and history of constipation in respective order; and low risk (1.5 < OR ≤ 2) consisted of grumpy father, particular diet (beverages, nuts, spicy soup) and history of diarrhoea.
Table 1

Assessment of the risk factors related to IBS (n = 454).

CharacteristicIBS (+)
IBS (−)
TotalP valueOR95% CI
n (%)n (%)
Age
 - 14–16 Y110 (80,3)225 (70,9)3350,051*1,671025–2708
 - 17–18 Y27 (19,7)92 (29,1)119
Gender
 - Female102 (74,5)183 (57,7)2850,001*2,131369–3326
 - Male35 (25,2)134 (42,5)169
Nutritional status
 - Malnourish37 (27,0)98 (30,9)1350,469*0,830,529–1292
 - Good100 (73,0)219 (69,1)319
Gestational age
 - Preterm3 (2,2)5 (1,6)80,702**1,400,329–5929
 - A term134 (97,8)312 (98,4)446
Birth weight
 - <2500 g2 (1,5)3 (0,9)50,640**1,560,256–9386
 - ≥2500 g135 (98,5)314 (99,1)449
No of sibling
 - ≤235 (25,5)79 (24,9)1140,981*1,030,652 –1639
 - >2102 (74,5)238 (75,3)340
Birth order
 - ≤3109 (79,6)277 (87,4)3860,046*0,560,330–0,956
 - >328 (20,4)40 (12,6)68
Parents' marital status
 - Married116 (84,7)283 (89,3)3990,221*0,660,370–1192
 - Divorced21 (15,3)34 (10,7)55
Mother's behavior
 - Grumpy45 (32,8)83 (26,2)1280,182*1,380,892–2132
 - Patient92 (67,2)234 (73,8)326
Father's behavior
 - Grumpy35 (25,5)53 (16,7)880,040*1,711053–2774
 - Patient102 (74,5)264 (83,3)366
Psychosocial problems
 - Being attacked24 (37,5)40 (62,5)640,219**1,470,847–2553
 - Sexual abuse4 (100)0 (0)40,008**3,382934–3902
 - Fighting29 (31,2)64 (68,8)930,912*1,060,648–1738
 - Bullying12 (52,2)11 (47,8)230,034*2,671148–6212
 - Trauma18 (30,0)42 (70,0)601000*0,990,548–1791
 - Negative emotions33 (31,4)72 (68,6)1050,843*1,080,674–1730
 - Abuse2 (100)0 (0)20,091**3,352907–3856
Diet
 - Fish cake101 (31,0)225 (69,0)3260,629*1,150,731–1801
 - Sweet layer cakes6 (31,6)13 (68,4)191000*1,070,398–2879
 - Spicy soup (Pindang)84 (34,4)160 (65,6)2440,043*1,561034–2339
 - Steam spicy fish22 (29,7)52 (70,3)741000*0,980,566–1680
 - Milk100 (31,1)222 (68,9)3220,599*1,160,740–1809
 - Canned foods72 (31,7)155 (68,3)2270,540*1,160,775–1729
 - Processed meats60 (31,1)133 (68,9)1930,794*1,080,719 -1616
 - Nuts70 (38,9)110 (61,1)1800,002*1,971309–2954
 - Fried snacks125 (31,3)274 (68,7)3990,226*1,600,813–3138
 - Tea81 (31,0)180 (69,0)2610,719*1,100,733–1653
 - Coffee29 (26,6)80 (73,4)1090,417*0,790,491–1288
 - Beverages96 (35,7)173 (64,3)2690,003*1,951271–2988
Eating duration
 - ≤10 min10 (7,3)24 (7,6)3410000,960,447–2069
 - >10 min127 (92,7)293 (92,4)420
Previous illness
 - Diarrhoea35 (41.2)50 (58.8)850.020*1.831.124–2.987
 - Constipation24 (44.4)30 (55.6)540.023*2.031.139–3.626
 - Food allergies22 (34.4)50 (58.8)720.520*1.250.716–2.193
Family history illness
 Recurrent abdominal pain6 (7.4)4 (3.57)100.073**3.580.995–12.909

Chi square test (*Continuity correction, **Fisher's exact test).

Bold values indicates significance at P<0.05.

Assessment of the risk factors related to IBS (n = 454). Chi square test (*Continuity correction, **Fisher's exact test). Bold values indicates significance at P<0.05.

Association between IBS and Blastocystis infection

Blastocystis spp. was more prevalent among students with IBS than non-IBS (36.5% vs 28.6%) however there was no significant difference statistically (P = 0.325; PR = 1.4; 95% CI = 0.8–2.7). Students harbouring Blastocystis spp. infection had 1.6–1.8 times risk to suffer from IBS-Diarrhoea (IBS-D) or IBS-Unspecified (IBS-U) and unlikely to suffer from IBS-Constipation (Table 2).
Table 2

Association between IBS, IBS types and Blastocystis infection.

Blastocystis spp.IBS
IBS category
Yes(n = 137)No(n = 70)IBS-DIBS-CIBS-MIBS-U
Yes50(36.5%)20(28.6%)216914
No87(63.5%)50(71.4%)29202117
PR (CI 95%)1.41.60.50.81.8
(0.8–2.7)(0.8–3.1)(0.2–1.4)(0.3–1.8)(0.8–3.8)
P0.3250.2180.3100.7880.214

Note:

IBD-D = IBS with diarrhoea symptom.

IBS-M = IBS mix with either diarrhoea or constipation episode.

IBS-C = IBS with constipation symptom.

IBS-U = IBS unclassified.

Fisher's exact, P value = 0.05; PR = prevalence ratio; CI = confidence interval.

Association between IBS, IBS types and Blastocystis infection. Note: IBD-D = IBS with diarrhoea symptom. IBS-M = IBS mix with either diarrhoea or constipation episode. IBS-C = IBS with constipation symptom. IBS-U = IBS unclassified. Fisher's exact, P value = 0.05; PR = prevalence ratio; CI = confidence interval.

Association between Blastocystis strain with IBS type

Blastocystis spp. was found in IBS and non-IBS subjects by direct stool microscopic examination i.e. in 50 out of 137 IBS subjects (36.5%) and 20 out of 70 non-IBS (28.6%). There were 43 out of 70 Blastocystis positive samples had successfully undergone PCR and sequencing (Table 3). Three subtypes of Blastocystis, ST-1, ST-2 and ST-3 were identified (Fig. 2).
Table 3

Distribution of Blastocystis subtypes among IBS and its association with IBS type.

Blastocystis strainIBS
IBS type
Yes(n-137)No(n = 70)IBS-DIBS-CIBS-MIBS-U
ST-1 (n = 20)15(10.9%)5(7.1%)9312
ST-2 (n = 2)2(1.5%)0(0%)0020
ST-3 (n = 21)14(10.2%)7(10.0%)3335

Note:

IBD-D = IBS with diarrhoea symptom.

IBS-M = IBS mix with either diarrhoea or constipation episode.

IBS-C = IBS with constipation symptom.

IBS-U = IBS unclassified.

Fig. 2

Phylogenetic tree of Blastocystis spp. isolated from adolescences in Palembang (PLB).

Distribution of Blastocystis subtypes among IBS and its association with IBS type. Note: IBD-D = IBS with diarrhoea symptom. IBS-M = IBS mix with either diarrhoea or constipation episode. IBS-C = IBS with constipation symptom. IBS-U = IBS unclassified. Phylogenetic tree of Blastocystis spp. isolated from adolescences in Palembang (PLB). There was higher proportion of ST-1 found in IBS group compared to the non-IBS (10.9% vs 7.1%), while ST-2 was found only in two students with IBS. The proportion of students harbouring Blastocystis ST-3 was similar between IBS and non-IBS (10.2% vs 10.0%); ST-3 did not show to affiliate to particular type of IBS (Table 3). Further analysis showed that students infected with Blastocystis ST-1 were 2.9 times more likely to develop IBS-D which was statistically significant (Fisher's exact, P = 0.029, P < 0.05; 95% CI = 1.1–7.5). This finding suggests that ST-1 is likely to be the strain of Blastocystis associated with clinical manifestation IBS-diarrhoea type.

Discussion

Irritable Bowel Syndrome is a common disorder among adolescences with higher prevalence in western than Asian countries and was believed as a functional bowel disorder (Dong et al., 2005; Chang et al., 2010; Saito and Schoenfeld, 2002) This study showed higher prevalence of IBS among high school students in Indonesia compared to other Asian countries (Dong et al., 2005; Chang et al., 2010; Fillekes et al., 2014). The prevalence of IBS varies greatly among epidemiological studies (Dong et al., 2005; Saito and Schoenfeld, 2002; Rey and Talley, 2009; Canavan et al., 2014), potentially due to the criteria chosen to diagnose IBS, inclusion and exclusion criteria, gender distribution and sociodemographic factors. The Rome III Diagnostic Questionnaire for Paediatric Functional GI Disorders was used to diagnose IBS in this study (Hyams et al., 2016) which is different from the adult questionnaire, in which criteria had to be fulfilled for the prior three months with symptoms onset at least six months prior to diagnosis. The risk factors significantly associated to IBS have been identified and can be classified into high risk factors: family history of recurrent abdominal pain and abuse; moderate risk factors: bullying, Blastocystis infection, female gender, history of constipation in the last 6 months and low risk factors: beverages, nuts, previous illness diarrhoea. Our study showed a moderate risk for female students to develop IBS, which was also observed in other similar studies (Rey and Talley, 2009; Anbardan et al., 2012). The gender difference in developing IBS is less dramatic in developing countries compared to western population (Rey and Talley, 2009) which could be due to gender-related effects on intestinal motor and sensory pathway and function (Baysoy et al., 2014). Negative emotion such as psychosocial problem and abuse have long been recognized to be associated with IBS in adolescences (Chang et al., 2010; Rey and Talley, 2009); while Park et al. specifically addressed that early adverse life events increased the odds of having IBS; correlated with IBS severity and abdominal pain (Park et al., 2016). History of previous diarrhoea and constipation in the last six months also showed significant association with IBS with the risk factor about twice, suggesting a post infection-IBS resembling to IBS-D, as a common result of acute gastroenteritis (Harper et al., 2018). However, the risk factor of family history of recurrent abdominal pain has the highest odd to develop IBS, implying possibility of hereditary role in IBS. There was a moderate risk for students harbouring Blastocystis infection to develop IBS. The overall prevalence of Blastocystis infection among the IBS group was higher than the non-IBS; more than one third of IBS students infected with Blastocystis spp. The IBS students harbouring Blastocystis, mostly suffered from IBS-diarrhoea (IBS-D) or IBS-U with estimated risk factor 1.6–1.8 times. Data prevalence of Blastocystis with IBS types was previously reported among adults and children <5 years, which showed an association between IBS-D and Blastocystis; while no reports among adolescence. There had also been no previous clear reports on association between IBS type and Blastocystis strain (Yakoob et al., 2010a, Yakoob et al., 2004); therefore this is the first report on complete assessment of IBS and in-depth analysis on the role of Blastocystis to IBS among adolescence. In view of its pathogenic and non-pathogenic Blastocystis strains, three Blastocystis subtypes, ST-1, ST-2 and ST-3 were identified in this study; no significant association with IBS was observed. However, there was significant association between Blastocystis ST-1 with IBS-Diarrhoea with the risk factor 2.9 times; suggesting that Blastocystis ST-1 is likely to associate to the clinical manifestation diarrhoea and possibility of being a pathogenic strain. Blastocystis ST-3 and ST-1 are the main subtypes found among populations in China, Japan, Bangladesh, Pakistan, Malaysia, Germany, Indonesia, Egypt (Sari et al., 2018; Li et al., 2007; Yoshikawa et al., 2004; Hussein et al., 2008; Tan, 2008). In view of possible pathogenic ST-1 in our study is in accordance to other studies such as in Egypt by Hussein et al. (2008) who demonstrated Blastocystis ST-1, isolated from patient with IBS caused mortality in rats and severe pathological changes, while Fouad et al. (2011) reported severe inflammatory changes in recto sigmoidal biopsy of IBS patients harbouring Blastocystis ST-1. Blastocystis ST-1 was also commonly found among IBS-D in Pakistan (Yakoob et al., 2010b). A meta-analysis by Rostami et al. (2017) involving 17 studies, showed the potential risk factors for IBS in patients infected by ST-1 and ST-3 subtypes with OR 4.40 and 1.94 respectively. Blastocystis ST-3 was not associated with any IBS types; it is found in equal proportion among the four types of IBS. This finding is in agreement to Ragavan et al. (2014), that showed phenotypic variation within Blastocystis ST-3. The prevalence of Blastocystis was investigated only by microscopic methods in this study, which is not possible to determine the exact prevalence of Blastocystis infection in the study population. It is necessary to do culture for better accuracy of diagnostic purpose (Stensvold, 2015). As culture facilities at the sample collection area was not available, not all cultures grew well at room temperature and subsequently affected the proportion of positive PCR results and subtype analysis. This situation has significant limitations to the study. However, in primary healthcare setting, microscopic examination should be considered as first line screening when handling IBS-D cases.

Conclusion

IBS in Indonesia was not merely functional bowel disorder, it has possible relationship with organic problem i.e. Blastocystis infection. Three subtypes of Blastocystis were observed (ST-1, ST-2 and ST-3) and ST-1 is considered to be a potential pathogenic species of Blastocystis spp., associated with IBS-diarrhoea type.
  33 in total

1.  Recurrent abdominal pains: a field survey of 1,000 school children.

Authors:  J APLEY; N NAISH
Journal:  Arch Dis Child       Date:  1958-04       Impact factor: 3.791

2.  DNA barcoding of blastocystis.

Authors:  Stephanie M Scicluna; Blessing Tawari; C Graham Clark
Journal:  Protist       Date:  2006-01-23

3.  In-vitro cultivation: a sensitive method for detecting Blastocystis hominis.

Authors:  S Leelayoova; P Taamasri; R Rangsin; T Naaglor; U Thathaisong; M Mungthin
Journal:  Ann Trop Med Parasitol       Date:  2002-12

4.  An epidemiologic study of irritable bowel syndrome in adolescents and children in China: a school-based study.

Authors:  Liu Dong; Li Dingguo; Xu Xiaoxing; Lu Hanming
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

5.  Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries.

Authors:  Hisao Yoshikawa; Zhiliang Wu; Isao Kimata; Motohiro Iseki; Ibne Karim M D Ali; Momammad B Hossain; Viqar Zaman; Rashidul Haque; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2003-11-04       Impact factor: 2.289

Review 6.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis.

Authors:  Javed Yakoob; Wasim Jafri; Nadim Jafri; Rustam Khan; Muhammad Islam; M Asim Beg; Viqar Zaman
Journal:  Am J Trop Med Hyg       Date:  2004-04       Impact factor: 2.345

8.  Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats.

Authors:  Eman M Hussein; Abdalla M Hussein; Mohamed M Eida; Maha M Atwa
Journal:  Parasitol Res       Date:  2008-01-11       Impact factor: 2.289

9.  Molecular epidemiology of human Blastocystis in a village in Yunnan province, China.

Authors:  Lan-Hua Li; Xiao-Nong Zhou; Zun-Wei Du; Xue-Zhong Wang; Li-Bo Wang; Jin-Yong Jiang; Hisao Yoshikawa; Peter Steinmann; Jürg Utzinger; Zhiliang Wu; Jia-Xu Chen; Shao-Hong Chen; Ling Zhang
Journal:  Parasitol Int       Date:  2007-06-14       Impact factor: 2.230

Review 10.  The epidemiology of irritable bowel syndrome in North America: a systematic review.

Authors:  Yuri A Saito; Philip Schoenfeld; G Richard Locke
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  9 in total

1.  Molecular Epidemiology and Risk Factors of Blastocystis sp. Infections Among General Populations in Yunnan Province, Southwestern China.

Authors:  Yao Deng; Shunxian Zhang; Chaoqun Ning; Yongkang Zhou; Xuejiao Teng; Xiuping Wu; Yanhong Chu; Yingfang Yu; Jiaxu Chen; Liguang Tian; Wei Wang
Journal:  Risk Manag Healthc Policy       Date:  2020-09-29

2.  Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats.

Authors:  Frédéric Antonio Carvalho; Philippe Poirier; Manon Defaye; Céline Nourrisson; Elodie Baudu; Amandine Lashermes; Maëva Meynier; Mathieu Meleine; Ivan Wawrzyniak; Virginie Bonnin; Julie Barbier; Benoit Chassaing; Catherine Godfraind; Agathe Gelot; Nicolas Barnich; Denis Ardid; Mathilde Bonnet; Frédéric Delbac
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

3.  Epidemiology of Blastocystis infection from 1990 to 2019 in China.

Authors:  Chao-Qun Ning; Zhu-Hua Hu; Jun-Hu Chen; Lin Ai; Li-Guang Tian
Journal:  Infect Dis Poverty       Date:  2020-12-30       Impact factor: 4.520

4.  LncRNA H19 as a Competing Endogenous RNA to Regulate AQP Expression in the Intestinal Barrier of IBS-D Patients.

Authors:  Guanqun Chao; Zhaojun Wang; Yi Yang; Shuo Zhang
Journal:  Front Physiol       Date:  2021-01-12       Impact factor: 4.566

5.  Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established?

Authors:  Fernando Salvador; Beatriz Lobo; Lidia Goterris; Carmen Alonso-Cotoner; Javier Santos; Elena Sulleiro; Begoña Bailo; David Carmena; Adrián Sánchez-Montalvá; Pau Bosch-Nicolau; Juan Espinosa-Pereiro; Isabel Fuentes; Israel Molina
Journal:  Biology (Basel)       Date:  2021-04-19

Review 6.  The Role of lncRNAs in Regulating the Intestinal Mucosal Mechanical Barrier.

Authors:  Shanshan Chen; Chi Zhang; Beihui He; Ruonan He; Li Xu; Shuo Zhang
Journal:  Biomed Res Int       Date:  2021-11-15       Impact factor: 3.411

7.  Substantial Intestinal Microbiota Differences Between Patients With Ulcerative Colitis From Ghana and Denmark.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Katleen Vranckx; Henrik Vedel Nielsen; Lee O'Brien Andersen; Timothy Archampong; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Front Cell Infect Microbiol       Date:  2022-03-03       Impact factor: 5.293

8.  Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.

Authors:  Freddy Franklin; Arutchelvan Rajamanikam; Chandramathi Samudi Raju; Jesjeet Singh Gill; Benedict Francis; Luke Woon Sy-Cherng; Suresh Kumar
Journal:  Parasit Vectors       Date:  2022-09-05       Impact factor: 4.047

9.  Blastocystis One Health Approach in a Rural Community of Northern Thailand: Prevalence, Subtypes and Novel Transmission Routes.

Authors:  Vasana Jinatham; Sadiya Maxamhud; Siam Popluechai; Anastasios D Tsaousis; Eleni Gentekaki
Journal:  Front Microbiol       Date:  2021-12-09       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.